Latest GM & Biosafety Resources

Press Release Ouagadougou, August 22, 2025 Target Malaria is a research consortium led by Imperial College London, which receives core funding from the Bill and Melinda Gates Foundation to apparently eradicate malaria in Africa. The first phase of its project in Burkina Faso has been a dismal failure, involving the release of GM mosquitoes. We […]

S’attaquer aux risques, au battage médiatique et aux inégalités qui sous-tendent la biologie générative Click here for the English version. Haga clic aquí para la versión en español. Le Centre africain pour la biodiversité (ACB), en collaboration avec le Réseau Tiers-monde (TWN) et l’ETC Group, a produit une note d’information opportune avant la 16e réunion […]

Afrontar los riesgos, exageraciones y desigualdades de la biología generativa Click here for the English version. Cliquez ici pour la version française. El Centro Africano para la Biodiversidad (ACB), junto con la Third World Network (TWN) y el ETC Group, han elaborado un oportuno documento informativo de cara a la 16ª reunión de la Conferencia […]

Addressing the risks, hype, and inequities underpinning generative biology Haga clic aquí para la versión en español. Cliquez ici pour la version française. The African Centre for Biodiversity (ACB), together with Third World Network (TWN) and ETC Group, have produced a timely briefing paper ahead of the 16th meeting of the Conference of the Parties […]

Food sovereignty alliance from Latin America, Africa, and Asia approaches seven UN Special Rapporteurs for urgent intervention to block cultivation and trade of GM wheat HB4 To date over 100 organisations endorse this submission. Please note the deadline for endorsements is Wednesday 15 February. PRESS RELEASE 30 January 2024 On 26 January 2024, a submission […]

(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]

Regulatory issues and threats for Africa Veuillez cliquer ici pour le français Clique aqui para a versão portuguesa Por favor, haga clic aquí para el español Genome editing risks aggravating the problems of industrial agriculture, prolonging a model that threatens both human health and the environment, and further opens up African food systems to hegemonic […]

Cliquez ici pour le français The ACB shares this research paper with you, of the wave of ‘Trojan horse’ second-generation genetic engineering strategies targeted at, inter alia, malaria in Africa, at a time when the COVID-19 crisis is fracturing the myth that global health expertise is the domain of North America and Europe. Global health […]

(Cliquez ici pour le français) Conducted silently and out of the public eye, a three-year experiment involving a new and potentially unsafe and risky genetically modified (GM) fungus to kill mosquitoes was performed in the village of Soumousso in Burkina Faso in 2019. When the study was published in a US scientific journal in May […]

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]

Resounding no to Monsanto’s ‘bogus’ GM drought tolerant maize: South Africa’s Minister, Appeal Board and Biosafety Authority Reject Monsanto’s GM seeds Johannesburg, South Africa, 4 October 2019 After more than 10 years of battling Monsanto’s ‘bogus’ drought tolerant maize project, the African Centre for Biodiversity (ACB) welcomes the decision by the Minister of Agriculture, Ms. […]

The African Centre for Biodiversity (ACB) has produced a briefing paper in regard to a new and controversial genetic engineering (GE) technology to produce gene drive organisms (GDOs). These GDOs have been specifically designed to spread an engineered, ‘modified’ genetic trait such as sterility, with the potential to eradicate entire wildlife populations and even species. […]